Tell HN: An inside view of Montana's new biotech law
Montana's SB535 law allows sponsors of IND-stage drugs to charge for experimental treatments outside clinical trials, aiming to address delays in drug approval. It introduces a new regulatory framework with oversight, safety reporting, and the potential to accelerate drug development and real-world data collection. (news.ycombinator.com)
